Are Rocephin (ceftriaxone) and Zmax (azithromycin) safe during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Rocephin (Ceftriaxone) and Zmax (Azithromycin) During Pregnancy

Both Rocephin (ceftriaxone) and Zmax (azithromycin) are safe to use during pregnancy when clinically indicated, as the benefits generally outweigh potential risks.

Azithromycin Safety in Pregnancy

Azithromycin is considered safe for use during pregnancy based on multiple guidelines and FDA labeling:

  • Classified as FDA Pregnancy Category B, indicating no evidence of harm to the fetus in animal studies 1
  • Recommended for use in pregnant patients with various infections, including for treatment of chlamydial infections 2
  • North American clinical practice guidelines specifically recommend azithromycin for pregnant patients requiring systemic antibiotics 3

Evidence Supporting Safety:

  • Reproduction studies in animals showed no evidence of embryotoxicity, fetotoxicity, or teratogenicity 1
  • No dosage adjustment is required during pregnancy 2
  • Standard dosing can be maintained as pharmacokinetic properties are not significantly altered during pregnancy 4

Potential Concerns:

  • Some conflicting research exists regarding potential risks, with some studies suggesting possible associations with adverse outcomes, though evidence is not conclusive 5
  • Should be used only when clinically indicated and benefits outweigh potential risks 2, 5

Ceftriaxone Safety in Pregnancy

Ceftriaxone is also considered safe for use during pregnancy:

  • FDA labeling states: "Reproductive studies have been performed in mice and rats at doses up to 20 times the usual human dose and have no evidence of embryotoxicity, fetotoxicity or teratogenicity" 6
  • No dosage adjustment is required during pregnancy 7

Evidence Supporting Safety:

  • Pharmacokinetic studies show that during the third trimester of pregnancy, ceftriaxone pharmacokinetics are similar to those in non-pregnant subjects 7
  • Has been successfully used as an alternative treatment for syphilis in pregnant women with penicillin allergy 8

Clinical Recommendations

When to Use:

  1. Azithromycin:

    • First-line for chlamydial infections during pregnancy 2
    • Preferred for MAC prophylaxis in HIV-infected pregnant women 2
    • Recommended for hidradenitis suppurativa requiring systemic antibiotics during pregnancy 3
  2. Ceftriaxone:

    • Appropriate for severe bacterial infections during pregnancy
    • Alternative for treatment of syphilis in penicillin-allergic pregnant women 8
    • No need for dosage adjustment during pregnancy 7

Precautions:

  • Monitor for common side effects of both medications
  • Azithromycin should not be used concomitantly with medications that can prolong the QT interval 2
  • When using azithromycin with protease inhibitors, close monitoring is recommended due to potential drug interactions 2, 1

Alternatives to Consider

If either medication is contraindicated:

  • For chlamydial infections: amoxicillin 500mg orally three times daily for 7 days 2
  • For bacterial infections requiring cephalosporins: cefuroxime is compatible with pregnancy 3

Follow-up Recommendations

  • For STI treatment: test of cure 3 weeks after treatment completion 2
  • Monitor for treatment response and potential side effects

Remember that while both medications are considered safe in pregnancy, they should be used only when clinically indicated and when the benefits outweigh the potential risks.

References

Guideline

Azithromycin Use in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacokinetic properties of azithromycin in pregnancy.

Antimicrobial agents and chemotherapy, 2010

Research

Pharmacokinetics and protein binding of ceftriaxone during pregnancy.

Antimicrobial agents and chemotherapy, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.